Updated July 2 at 5:02pm

EpiVax team publishes research on H7N9 flu; plans vaccines

PROVIDENCE – A research paper on the emerging threat from the H7N9 flu, written by Dr. Annie De Groot and her team at EpiVax, has been published by the journal Human Vaccines & Immunotherapeutics.

To continue reading this article, please do one of the following.



Sign up to receive Providence Business News' newsletters
and breaking news alerts.  

health care

EpiVax team publishes research on H7N9 flu; plans vaccines

Posted:

PROVIDENCE – A research paper on the emerging threat from the H7N9 flu, written by Dr. Annie De Groot and her team at EpiVax, has been published by the journal Human Vaccines & Immunotherapeutics.

The article, “Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design,” detailed how De Groot and her team used well-established immunoinformatics tools to analyze the H7N9 protein sequences.

The research found that protein derived from closely related human-derived H7N9 strains contain fewer T cell epitopes than other recently circulating strains of influenza.

Based on that research, De Groot and her team have developed four separate vaccine recipes that are now in production.

EpiVax, a Providence-based bioscience firm, celebrated its 15th birthday on May 17 at its headquarters in the city’s Knowledge District. •

28~07, 052013 HEALTH CARE NEWS BRIEFS, EpiVax, 28~07, issue052013export.pbn

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment
Latest News